CIK 0000939767
- Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043257395
- Phone
- +1 650-837-7000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- 4 Planned sale EVP, General Counsel & Sec sold 50,000 shares at an average $22.04 ($1,101,750)
- 4 Open-market buy Director bought 120,409 shares at $21.61 ($2,602,038)
- 4 Gift President and CEO gave 19,020 shares (gift)
- 4 Gift President and CEO gave 116,893 shares (gift)
- 4 Shares withheld for taxes President and CEO gave up 46,608 shares (to pay taxes)
- 4 Shares withheld for taxes EVP and CFO gave up 17,147 shares (to pay taxes)
- 4 Shares withheld for taxes CSO/EVP Disc & Trans Research gave up 12,560 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Commercial gave up 14,354 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, General Counsel & Sec gave up 14,354 shares (to pay taxes)
- 4 Gift President and CEO gave 113,721 shares (gift)
- 4 Planned sale CSO/EVP Disc & Trans Research sold 4,600 shares at $22.47 ($103,362)
- 4 Shares withheld for taxes President and CEO gave up 303,779 shares (to pay taxes)
- 4 Grant or award EVP Prod Dev & Med Aff & CMO acquired 240,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes President and CEO gave up 23,304 shares (to pay taxes)
- 4 Shares withheld for taxes EVP and CFO gave up 8,074 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, General Counsel & Sec gave up 7,177 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Commercial gave up 7,177 shares (to pay taxes)
- 4 Shares withheld for taxes CSO/EVP Disc & Trans Research gave up 6,280 shares (to pay taxes)
- 4 Open-market sale EVP and CFO sold 120,000 shares at an average $20.60 ($2,471,400)
Page 10 of 73 · 1,458 filings